A randomised trial to compare dolutegravir+darunavir/r versus recommended standard of care antiretroviral regimens in patients with HIV infection who have failed recommended first line therapy

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1104610

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Public sector programs for provision of antiretroviral drugs in developing countries need regimens of therapy that are safe, effective and simple to administer. The evidence base to support first line therapy is strong. This contrasts with a relative paucity of evidence for second regimens of therapy once first line effectiveness has been lost. This trial will address that evidential deficit and support evidence-based recommendations for global health.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2019

Funding Scheme: Project Grants

Funding Amount: $2,323,209.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Infectious Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

acquired immunodeficiency syndrome (AIDS) | antiretroviral therapy | developing countries | human immunodeficiency virus (HIV) | randomised controlled trial (RCT)

Related Links